Sinopia Biosciences
Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
About
Sinopia Biosciences is a biotechnology company focused on developing novel therapeutics. They leverage their proprietary LEADSĀ® (LEarn And DiScover) drug discovery platform, which utilizes metabolomics-driven discovery capabilities. The company has received a research grant from the National Cancer Institute (NCI) to expand the application of its platform to oncology. Teams look it up for Biotechnology, Drug Discovery, Oncology.
Frequently asked
What does Sinopia Biosciences do?
Sinopia Biosciences is a Biotechnology company that offers Platform. Teams look it up for Drug Discovery, Oncology, Biotech. It is based in San Diego, California, USA and was founded in 2017. Public records show $2M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised a total of $2M in funding. The most recent round on record is Grant.
Where is Sinopia Biosciences headquartered?
Sinopia Biosciences is headquartered in San Diego, California, USA.
When was Sinopia Biosciences founded?
Sinopia Biosciences was founded in 2017.
What industry does Sinopia Biosciences operate in?
Sinopia Biosciences operates in Biotechnology, Drug Discovery, Oncology, Biotech, AI Drug Discovery.
Strength of the siteās backlink profile, on Ahrefsā 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the companyās own site. Measured by Google, not by us.